Yeah their tech is better then ours they use a form of shrna that performs like both rani and shrna. You see one type of shrna requires the use of the cleaver enzyme to active it, while the other type does not which makes it react much faster since you get to skip a step, I'm not sure if benitec can lay claim to this form of shrna consider they have lost lesser battles, but they are free to utilize. Say they had used this form in the hep c trial viral load drop would have been observered at the lower doses, but oh well it is my hope that after a deal is done they will tweak the tech and is a faster acting form of shrna that does not require the use of the clever enzyme. In damaged cells the cleaver enzyme can be damaged as well effectively neutralizing the treatment
- Forums
- ASX - By Stock
- BLT
- Latest success for Gradalis
Latest success for Gradalis, page-2
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online